Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 ; volume:8 ; number:1 ; day:16 ; month:7 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (16.7.2018), 1-13, 12.2018
- Urheber
-
Lee, Jei Ha
- Beteiligte Personen und Organisationen
-
Choi, Soo Im
Kim, Rae Kwon
Cho, Eun Wie
Kim, In Gyu
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-29142-x
- URN
-
urn:nbn:de:101:1-2018091821180748041221
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jei Ha
- Choi, Soo Im
- Kim, Rae Kwon
- Cho, Eun Wie
- Kim, In Gyu
- SpringerLink (Online service)
Ähnliche Objekte (12)
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness
circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia
TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling
Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
HSP90 facilitates stemness and enhances glycolysis in glioma cells
HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation
NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness
circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia
TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling
Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
HSP90 facilitates stemness and enhances glycolysis in glioma cells
HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation
NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness
circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
Aberrant activation of TGF-β/ROCK1 enhances stemness during prostatic stromal hyperplasia
TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling
Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
HSP90 facilitates stemness and enhances glycolysis in glioma cells
HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation